2026 Abacus dx Emerging Investigators Grant

NOW OPEN

$50,000 Grant in Research Funding

Empowering the Next Generation of Scientific Leaders

We’re thrilled to announce the launch of the 2026 Abacus dx Emerging Investigators Grant, a $50,000 AUD initiative supporting early-career researchers and PhD students across Australia.*

This grant funds reagents for projects in:

Protein Quantification | Spatial-Histology Biology | Molecular Sequencing | Other areas of Life Science research

---

Why Apply For The Grant?

• Showcase your research
• Access innovative technologies
• Gain national recognition
• Connect with global suppliers

Applications are now open!

📣 Submission deadline: 28^th February 2026

---

* The following terms and conditions apply: 

• Funding may only be spent with Abacus dx, on the products (excluding instruments) outlined in Grant Application. 
• Preference will be given to projects that align with the Abacus dx Life Science portfolio offering.
• Preference will be given to early-career researchers and PhD students.
• Abacus dx will be acknowledged in all resulting publications and presentations.
• 3 month progress reports must be submitted to the Abacus dx.
• There may be multiple grants awarded for varying value.
• The successful applicant may be asked to present their work at Abacus dx events.
• The research funds are to be used for the project, as per the budget application only. Abacus dx does not support an institution’s infrastructure or overhead costs. 
• The application will be sent via email after completing the request form at the end of this page. 

The grant application and CV will be assessed by a panel of at least three independent reviewers using a standardised scoring system. Applicants will be informed of the decision on the 30^th of April 2026, and the grant will be valid until the 30^th of August 2026. 

Please read through the grant guidelines document before beginning your application.

For enquiries on the application please contact the Gabriela Spaniol at [email protected]  

For enquiries on product portfolio and pricing, please contact your local business development specialist who will need to assist you when completing the budget template spreadsheet. Please email the completed budget template spreadsheet to your local representative below after you have finished your application.

---

Contact your local representative to learn more

Our Supplier Partners

Roche’s LightCycler systems offer precise, high-throughput real-time PCR solutions, while KAPA products provide innovative sequencing technologies for advanced genomic research.

See the Roche Portfolio here: Roche KAPA Sequencing Catalog 

The MILLIPLEX portfolio of immunoassays is the largest portfolio of catalogue and custom multiplex biomarker assays, offering consistent, high-quality results.

See the Merck Analyte Quarterly brochure here.

Cytek’s Muse Micro and Guava portfolio offers affordable, user-friendly cell analysers designed for simplified and precise flow cytometry and off-the-shelf kits.

See the Muse Micro Cell Analyzer instrument and EasyCyte and Muse Micro kits.

Market leader in labelling and detection reagents for immunohistochemistry, immunofluorescence, glycobiology and bioconjugation.

Check out the Vector’s IHC Resource and IF Resource Guides for a list of products, as well as on their website, VectorLabs. 

An innovative company from Japan develops synthetic peptide alternatives to growth factors.

View the PeptiGrowth Portfolio here, and on their website, PeptiGrowth.

Industry leader in RNA and IVT, TriLink are responsible for the development of CleanCap technology.

See the TriLink portfolio at their website here.

Offers top-quality antibodies and assay kits with rigorous in-house validation (including over 9,500 polyclonal catalogue products; 120+ recombinant and monoclonal products and 1,300 secondary antibodies and protiens across 25 species.

See more about Bethyl’s Flow Cytometry validated antibodies.  

Specialising in the production and conjugation of affinity-purified secondary antibodies. Manufactured in the USA.

View the Jackson antibodies and conjugates portfolio here, and on their website, Jackson ImmunoResearch.

nanoComposix, a Fortis Life Sciences company, specialises in the design, development, and scalable manufacturing of precisely engineered and highly characterised nanomaterials for applications in therapeutics, diagnostics, energy, and optics. With over 20 years of expertise, they provide monodisperse metal, metal oxide, and silica nanoparticles, along with custom solutions and CDMO services to support research through to commercialisation.

Check out their portfolio here: nanoComposix 

World leaders; one of the largest ranges of peptides, antibodies, kits & biomarker assays. Manufactured in the USA.

Check out Phoenix portfolio of peptides, antibodies and assay kits here.